Cited by 129Viral Infectious Diseases and Gene Expression in InsectsAnimal Genetics and ReproductionTransgenic Plants and Applications

Advances in animal cell recombinant protein production: GS-NS0 expression system

Open access
Barnes, Louise M., Bentley, Catherine M., Dickson, Alan J.·2000·Cytotechnology

Abstract

The production of recombinant proteins using mammalian cell expression systems is of growing importance within biotechnology, largely due to the ability of specific mammalian cells to carry out post-translational modifications of the correct fidelity. The Glutamine Synthetase-NS0 system is now one such industrially important expression system.Glutamine synthetase catalyses the formation ofglutamine from glutamate and ammonia. NS0 cellscontain extremely low levels of endogenous glutaminesynthetase activity, therefore exogenous glutaminesynthetase can be used efficiently as a selectablemarker to identify successful transfectants in theabsence of glutamine in the media. In addition, theinclusion of methionine sulphoximine, an inhibitor ofglutamine synthetase activity, enables furtherselection of those clones producing relatively highlevels of transfected glutamine synthetase and henceany heterologous gene which is coupled to it. Theglutamine synthetase system technology has been usedfor research and development purposes during thisdecade and its importance is clearly demonstrated nowthat two therapeutic products produced using thissystem have reached the market place.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1023/a:1008170710003

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Murine myeloma cells (NS0 and Sp2/0) are used to produce commercial monoclonal antibodies such as Cetuximab and Palivizumab.

    “Murine myeloma cells (NS0 and Sp2/0), derived from tumor cells that no longer produce their original immunoglobulins, also are being used to produce some commercial monoclonal antibodies such as Cetuximab (ERBITUX ® ) and Palivizumab (SYNAGIS ® ) (Barnes et al., 2000;Dumont et al., 2015).”

    From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Barnes et al., 2000

    The ‘Products generated using the GS-NS0 system’ section identifies Synagis (palivizumab) as a marketed monoclonal antibody produced using the GS-NS0 system. The ‘NS0 cell history’ section also describes NS0 as a non-secreting murine myeloma line. Our copy does not identify Sp2/0 or Cetuximab, so it does not support those parts of the attributed claim. (LLM, conf=0.89)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 17

  1. Bebbington CR & Hentschel CCG (1987) The use of vectors based on gene amplification for the expression of cloned genes in mam- malian cells. In: Glover D (ed.) DNA Cloning, Vol. III (pp. 163-188) Academic Press, New York.
  2. Birch JR, Bebbington CR, Field R, Renner G, Brand H & Fin- ney H (1993) The production of recombinant antibodies us- ing the glutamine synthetase (GS) system. In: Kaminogawa S, Ametani A & Hachimura S (eds.) Animal Cell Technology: Ba- sic and Applied Aspects, Vol. 5 (pp. 573-577) Kluwer Academic Publishers, Dordrecht.
  3. Field RP, Brand H, Renner GL, Robertson HA & Boraston R (1991) Production of a chimeric antibody for tumour imaging and therapy from Chinese hamster ovary (CHO) and myeloma cells. In: Spier RE, Griffiths JB & Meignier B (eds.) Produc- tion of Biologicals from Animal Cells in Culture (pp. 742-744)
  4. Field R, Cockett M & Froud SJ (1989) Glutamine synthetase amplification of TIMP expression in CHO cells. In: Spier RE, Griffiths JB, Stephenne J & Crooy PJ (eds.) Advances in Animal Cell Biology and Technology for Bioprocesses (pp. 195-197)
  5. Froud SJ, Clements GJ, Doyle ME, Harris ELV, Lloyd C, Mur- ray P, Preneta A, Stephens PE, Thompson S & Yarranton GT (1991) The development of a process for the production of HIV1 GP120 from recombinant cell lines. In: Spier RE, Griffiths JB & Meignier B (eds.) Production of Biologicals from Animal Cells in Culture (pp. 110-116)
  6. Galfrè G & Milstein C (1981) Preparation of monoclonal antibodies: strategies and procedures. In: Langone JJ & Vunakis HV (eds.) Methods in Enzymology, Vol. 73 (pp. 3-46) Academic Press, New York.
  7. Gofton CM, Roberts G, Bergin S & Owens RJ (1992) The rapid production of recombinant rabbit metalloproteinases in myeloma cells. In: Spier RE, Griffiths, JB & MacDonald C (eds.) Animal Cell Technology: Developments, Processes and Products (pp. 48-50)
  8. Hassell T, Brand H, Renner G, Westlake A & Field RP (1992) Sta- bility of production of recombinant antibodies from glutamine synthetase amplified CHO and NS0 cell lines. In: Spier RE, Griffiths, JB & MacDonald C (eds.) Animal Cell Technology: Developments, Processes & Products (pp. 42-47)
  9. Hovey A, Bebbington C & Jenkins N (1994b) Simultaneous control of growth and productivity using a mutant CHO cell line. In: Spier RE, Griffiths JB & Berthold W (eds.) Animal Cell Techno- logy: Products of Today, Prospects for Tomorrow (pp. 422-424)
  10. Jenkins N & Hovey A (1993a) Generation of CHO cell mutants for growth control. In: Kaminogawa S, Ametani A & Hachimura S (eds.) Animal Cell Technology: Basic and Applied Aspects, Vol 5 (pp. 267-272) Kluwer Academic Publishers, Dordrecht.
  11. Kingston RE, Kaufman RJ, Bebbington CR & Rolfe MR (1994) Amplification using CHO cell expression vectors. In: Ausubel FM et al. (eds.) Current Protocols in Molecular Biology. Unit 16.14 (pp. 16.14.1 -16.14.13).
  12. Meister A (1974) Glutamine synthetase of mammals. In: The Enzymes, Vol. X. 3 rd Edition (pp. 699-754) Academic Press.
  13. Meister A (1980) Catalytic mechanism of glutamine synthetase; overview of glutamine metabolism. In: Mora J & Palacios R (eds.) Glutamine: Metabolism, Enzymology and Regulation (pp. 1-40) Academic Press.
  14. Page MJ (1988) Expression of foreign genes in mammalian cells. In: Walker JM (ed.) Methods in Molecular Biology, Vol 4, New Nucleic Acid Techniques (pp. 371-384) The Humana Press.
  15. Ray NG, Rivera R, Gupta R & Mueller D (1997) Large-scale production of humanized monoclonal antibody expressed in a GS-NS0 cell line. In: Carrondo MJT, Griffiths B & Moreira JLP (eds.) Animal Cell Technology (pp 235-241) Kluwer Academic Publishers, Dordrecht.
  16. Robinson DK, Chan CP, Yu Ip CC, Seamans TC, Lee DK, Lenny AB, Tung J-S, DiStefano DJ, Munshi S, Gould SL, Tsai PK, Irwin J, Mark GE & Silberklang M (1994b) Product consistency during long-term fed-batch culture. In: Spier RE, Griffiths JB & Berthold W (eds.) Animal Cell Technology: Products of Today, Prospects for Tomorrow (pp. 763-767)
  17. Wang H & Imanaka (eds.) Antibody Engineering. American Chemical Society Symposium Series 604 (pp. 1-14) Washington DC.

Cited by

Sorted by citations

Authors
Barnes, L. M., Bentley, C. M., & Dickson, A. J.
Affiliations
University of Manchester (GB)
Venue
Cytotechnology
Published
2000-02
Volume
32
Issue
2
Pages
109-123
ISSN
  • 0920-9069 (ISSN-L)
  • 1573-0778
OpenAlex
W1498699116
Cited by
129
References
2
Citations by year
2026: 5 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 7 · 2017: 6 · 2016: 7 · 2015: 6 · 2014: 6 · 2013: 9 · 2012: 6
FWCI
1.09
Type
journal article
Language
en
Open access
Locations
  • Cytotechnology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Directorate for Biological Sciences
  • Biotechnology and Biological Sciences Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
Keywords
recombinant protein expression, mammalian cell expression systems, NS0 cells, glutamine synthetase, methionine sulfoximine, post-translational modification, therapeutic proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review